"It Can't Hurt!": Why Many Patients With Limited Life Expectancy Decide to Accept Lung Cancer Screening

CONCLUSIONS: Patients in this study with multimorbidity and limited life expectancy were unaware of their greater risk of potential harm when accepting LCS. Given patient trust in clinician recommendations, it is important that clinicians engage patients with marginal LCS benefit in shared decision making, ensuring that their values of desiring more information about their health are weighed against potential harms from further evaluations.PMID:38527813 | DOI:10.1370/afm.3081

Source: Annals of Family Medicine - March 25, 2024 Category: Primary Care Authors: Eduardo R N úñez Rendelle E Bolton Jacqueline H Boudreau Samantha K Sliwinski Abigail N Herbst Lauren E Kearney Tanner J Caverly Renda Soylemez Wiener Source Type: research